Bausch + Lomb Corp is making waves on the TSX with a notable gain, reflecting growing investor confidence.
Bausch + Lomb Corp (BLCO.TO) is rising today, with shares up by 1.53% to CA$25.28. This uptick comes amidst fresh insights into the company's market position and ongoing efforts to raise awareness about eye health issues, particularly among women experiencing menopause.
Advertisement
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.51B
52W high
$25.70
52W low
$19.36
1W change
+4.45%
Beta
0.55
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to rise 1.0% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.16
+1.0% Upside
Current Price
C$24.90
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
22.6%
Annualized
90-Day Vol
27.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$29.77
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$26.43 | C$24.44 – C$28.57 |
| 60 trading days | C$28.05 | C$25.12 – C$31.32 |
| 90 trading days | C$29.77 | C$26.01 – C$34.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find Bausch + Lomb's recent performance encouraging, especially given its commitment to addressing unmet needs in eye health and the potential for future growth.
1.53% Gain in One Day
Bausch + Lomb's stock has appreciated by 1.53%, reflecting a positive market reaction to its recent survey findings and ongoing product innovations.
Bull case
A recent survey showed that many women going through menopause are unaware that dry eye can be a symptom. This presents a chance for Bausch + Lomb to broaden its market reach and product offerings, which could boost revenue.
Bear case
Even with today’s gain, there are concerns about the company’s negative profit margins and the challenges it faces in implementing its growth strategies. These factors could affect long-term investor confidence.
Advertisement
Survey Highlights Eye Health Awareness Gap
A recent survey conducted by Bausch + Lomb revealed that only 14% of peri-, menopausal, and post-menopausal women recognize dry eye as a symptom of menopause. This surprising statistic underscores the need for greater awareness and education regarding eye health, particularly during significant life changes. The company aims to leverage these findings to enhance its marketing strategies and product offerings.
Market Performance and Investor Sentiment
Bausch + Lomb's stock performance today reflects a growing investor confidence in the company’s potential to capitalize on the insights gained from its survey. With a market cap of approximately CA$8.5 billion, the stock is seen as undervalued compared to its intrinsic value estimates. However, investors remain cautious due to the company's negative profit margins and the execution risks associated with its growth strategies.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
